
|Articles|February 26, 2020
Tufts CSDD Study Reveals Increased External Data Sources Contributing to Delays in Trial Completion
Advertisement
According to The Tufts-eClinical Solutions Data Strategies & Transformation Study, conducted in 2019 by eClinical Solutions LLC and the Tufts Center for the Study of Drug Development, the increasing volume and diversity of external data sources is contributing to longer database lock cycle times. The study indicates that industry leaders are adopting definitive data strategies along with modern technologies to increase control over the research process.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
4
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
5




